These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17474808)

  • 1. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
    Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
    J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature.
    Muench J; Carey M
    J Am Board Fam Pract; 2001; 14(4):278-82. PubMed ID: 11458971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
    Ramaswamy K; Kozma CM; Nasrallah H
    Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
    Vuk A; Kuzman MR; Baretic M; Osvatic MM
    Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Schizophrenia, diabetes mellitus and antipsychotics].
    Gury C
    Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset diabetes and ketoacidosis with atypical antipsychotics.
    Wilson DR; D'Souza L; Sarkar N; Newton M; Hammond C
    Schizophr Res; 2003 Jan; 59(1):1-6. PubMed ID: 12413635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
    Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data.
    Lipscombe LL; Austin PC; Alessi-Severini S; Blackburn DF; Blais L; Bresee L; Filion KB; Kawasumi Y; Kurdyak P; Platt RW; Tamim H; Paterson JM;
    Schizophr Res; 2014 Apr; 154(1-3):54-60. PubMed ID: 24581419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient.
    Lu CH; Yan YH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e66-7. PubMed ID: 19135753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA; Joyce AT; Rucker M
    MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk evaluation of diabetic ketoacidosis associated with antipsychotics among patients with schizophrenia in the Japanese adverse event report database.
    Sugawara N; Yasui-Furukori N; Shimoda K
    J Psychosom Res; 2023 Dec; 175():111533. PubMed ID: 37866219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.
    Nasrallah HA; Newcomer JW
    J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S7-14. PubMed ID: 15356415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics and diabetes mellitus: an association.
    Liberty IF; Todder D; Umansky R; Harman-Boehm I
    Isr Med Assoc J; 2004 May; 6(5):276-9. PubMed ID: 15151366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitus.
    Krosnick A; Wilson MG
    Clin Ther; 2005 Mar; 27(3):320-6. PubMed ID: 15878385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.
    Koller EA; Weber J; Doraiswamy PM; Schneider BS
    J Clin Psychiatry; 2004 Jun; 65(6):857-63. PubMed ID: 15291665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.
    Polcwiartek C; Kragholm K; Rohde C; Hashemi N; Vang T; Nielsen J
    Diabetologia; 2017 Sep; 60(9):1678-1690. PubMed ID: 28593353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.